Adage Capital Partners Gp, L.L.C. Kodiak Sciences Inc. Call Options Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KOD
# of Institutions
128Shares Held
44.4MCall Options Held
213KPut Options Held
224K-
Baker Bros. Advisors LP New York, NY17.3MShares$338 Million2.31% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$75.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.84MShares$55.4 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$38.1 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.27MShares$24.7 Million0.53% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $1.02B
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...